Anti-VEGF monoclonal antibody - Center of Molecular Immunology
Alternative Names: VEGF humanised monoclonal antibody - CIMABSLatest Information Update: 02 Oct 2021
At a glance
- Originator Center of Molecular Immunology
- Class Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors; Vascular endothelial growth factors inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Solid-tumours in Cuba (Parenteral)
- 22 Sep 2016 Preclinical trials in Solid tumours in Cuba (Parenteral) before September 2016 (CIMAB pipeline; January 2016)